IITRI NEWS

NEWS

We are ready to answer your questions and provide guidance.

News

Immunostain SARS-CoV-2 Efficacy Assay Available

Immunostain SARS-CoV-2 Efficacy Assay Available

IITRI now offers an improved efficacy assay for looking at effects of drugs on SARS-CoV-2. Although this assay no longer includes a cytotoxicity readout, we offer a neutral red assay in BSl-2 instead if needed. This current assay uses immunostaining and provides more...

IITRI has developed a new bleomycin mouse model

IITRI has developed a new bleomycin mouse model

IITRI now offers an improved bleomycin (BLM) induced pulmonary fibrosis mouse model that can recapitulate many of the complex profibrotic responses that are also observed in the lungs of those suffering from idiopathic pulmonary fibrosis (IPF) and perhaps COVID-19...

IITRI-Vaccine-Antiinfectives-Lunch-n-Learn

IITRI-Vaccine-Antiinfectives-Lunch-n-Learn

IITRI-Vaccine-Antiinfectives-Lunch-n-Learn Title: Regulatory Approval Pathways for Vaccines and Antivirals: Laying the Groundwork Location: MassBio, 300 Technology Square, 8th Floor, Cambridge MA, 02139 Date/Time: Tuesday, September 25, 2018 Registration: 11 am...

Zika Poster Presentation at ASM Biothreats 2018 Meeting

Zika Poster Presentation at ASM Biothreats 2018 Meeting

IITRI will be presenting a poster at the ASM Biothreats 2018 Meeting, February 12-14 in Baltimore, MD. For more details, please contact us. Title: Humoral and cellular immune dynamics following Zika virus secondary challenge in non-human primates. Authors: J. M....

Dave McCormick Presenting at Eurotox 2017

Dave McCormick Presenting at Eurotox 2017

Dave McCormick, IITRI's Director, will be presenting at Eurotox 2017 in a symposium session: Toxicology and Cellular Mechanisms of Electromagnetic Fields (EMF) – Health Aspects of Exposure to EMF Emitted by Wireless Mobile Systems and Emerging Technologies. His talk...